Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2024 Results
Westlake Chemical Partners LP (NYSE: WLKP) reported Q4 2024 net income of $15.0 million ($0.43 per unit), compared to $14.3 million in Q4 2023. Cash flows from operating activities increased to $132.5 million, up $24.8 million from Q4 2023.
For full-year 2024, net income reached $62.4 million ($1.77 per unit), an $8.1 million increase from 2023, driven by higher third-party ethylene sales prices and margins. Operating cash flows grew to $485.0 million, up $33.0 million from 2023.
The Partnership declared its 42nd consecutive quarterly distribution of $0.4714 per unit. The company deferred the planned Petro 1 ethylene unit turnaround to 2025, which helped exceed annual production plans and capture attractive third-party ethylene prices in H2 2024. The maintenance turnaround began in January 2025 and is expected to last approximately 60 days.
Westlake Chemical Partners LP (NYSE: WLKP) ha riportato un utile netto per il quarto trimestre 2024 di 15,0 milioni di dollari (0,43 dollari per unità), rispetto ai 14,3 milioni di dollari del quarto trimestre 2023. I flussi di cassa dalle attività operative sono aumentati a 132,5 milioni di dollari, con un incremento di 24,8 milioni di dollari rispetto al quarto trimestre 2023.
Per l'intero anno 2024, l'utile netto ha raggiunto i 62,4 milioni di dollari (1,77 dollari per unità), con un aumento di 8,1 milioni di dollari rispetto al 2023, sostenuto da prezzi di vendita dell'etilene di terze parti e margini più elevati. I flussi di cassa operativi sono cresciuti a 485,0 milioni di dollari, in aumento di 33,0 milioni di dollari rispetto al 2023.
La Partnership ha dichiarato la sua 42esima distribuzione trimestrale consecutiva di 0,4714 dollari per unità. L'azienda ha rinviato il previsto turnaround dell'unità di etilene Petro 1 al 2025, il che ha contribuito a superare i piani di produzione annuali e a catturare prezzi interessanti dell'etilene di terze parti nel secondo semestre del 2024. Il turnaround di manutenzione è iniziato a gennaio 2025 e si prevede che duri circa 60 giorni.
Westlake Chemical Partners LP (NYSE: WLKP) reportó un ingreso neto de 15,0 millones de dólares (0,43 dólares por unidad) en el cuarto trimestre de 2024, en comparación con 14,3 millones de dólares en el cuarto trimestre de 2023. Los flujos de efectivo de las actividades operativas aumentaron a 132,5 millones de dólares, un incremento de 24,8 millones de dólares con respecto al cuarto trimestre de 2023.
Para el año completo 2024, el ingreso neto alcanzó los 62,4 millones de dólares (1,77 dólares por unidad), un aumento de 8,1 millones de dólares en comparación con 2023, impulsado por precios de venta de etileno de terceros y márgenes más altos. Los flujos de efectivo operativos crecieron a 485,0 millones de dólares, un aumento de 33,0 millones de dólares con respecto a 2023.
La sociedad declaró su 42ª distribución trimestral consecutiva de 0,4714 dólares por unidad. La compañía postergó el giro planificado de la unidad de etileno Petro 1 para 2025, lo que ayudó a superar los planes de producción anuales y a capturar precios atractivos de etileno de terceros en el segundo semestre de 2024. El giro de mantenimiento comenzó en enero de 2025 y se espera que dure aproximadamente 60 días.
Westlake Chemical Partners LP (NYSE: WLKP)는 2024년 4분기 순이익이 1,500만 달러(주당 0.43달러)로 2023년 4분기의 1,430만 달러에 비해 증가했다고 보고했습니다. 운영 활동에서 발생한 현금 흐름은 1억 3,250만 달러로 증가했으며, 이는 2023년 4분기보다 2,480만 달러 증가한 수치입니다.
2024년 전체 연도에 대한 순이익은 6,240만 달러(주당 1.77달러)에 도달했으며, 이는 2023년보다 810만 달러 증가한 것입니다. 이는 제3자 에틸렌 판매 가격과 마진 상승에 의해 주도되었습니다. 운영 현금 흐름은 4억 8,500만 달러로 증가했으며, 이는 2023년보다 3,300만 달러 증가한 수치입니다.
파트너십은 주당 0.4714달러의 42번째 연속 분배금을 선언했습니다. 회사는 계획된 Petro 1 에틸렌 유닛의 정비를 2025년으로 연기했으며, 이는 연간 생산 계획을 초과하고 2024년 하반기에 매력적인 제3자 에틸렌 가격을 확보하는 데 도움이 되었습니다. 유지보수 정비는 2025년 1월에 시작되며 약 60일간 지속될 것으로 예상됩니다.
Westlake Chemical Partners LP (NYSE: WLKP) a annoncé un bénéfice net de 15,0 millions de dollars (0,43 dollar par unité) pour le quatrième trimestre 2024, contre 14,3 millions de dollars pour le quatrième trimestre 2023. Les flux de trésorerie provenant des activités opérationnelles ont augmenté à 132,5 millions de dollars, soit une hausse de 24,8 millions de dollars par rapport au quatrième trimestre 2023.
Pour l'année complète 2024, le bénéfice net a atteint 62,4 millions de dollars (1,77 dollar par unité), soit une augmentation de 8,1 millions de dollars par rapport à 2023, soutenue par des prix de vente d'éthylène de tiers et des marges plus élevées. Les flux de trésorerie d'exploitation ont augmenté à 485,0 millions de dollars, en hausse de 33,0 millions de dollars par rapport à 2023.
Le partenariat a déclaré sa 42e distribution trimestrielle consécutive de 0,4714 dollar par unité. L'entreprise a reporté le retournement prévu de l'unité d'éthylène Petro 1 à 2025, ce qui a permis de dépasser les plans de production annuels et de capter des prix d'éthylène de tiers attractifs au second semestre 2024. Le retournement de maintenance a commencé en janvier 2025 et devrait durer environ 60 jours.
Westlake Chemical Partners LP (NYSE: WLKP) meldete für das vierte Quartal 2024 einen Nettogewinn von 15,0 Millionen Dollar (0,43 Dollar pro Einheit), verglichen mit 14,3 Millionen Dollar im vierten Quartal 2023. Die Cashflows aus operativen Tätigkeiten stiegen auf 132,5 Millionen Dollar, was einem Anstieg von 24,8 Millionen Dollar gegenüber dem vierten Quartal 2023 entspricht.
Für das gesamte Jahr 2024 erreichte der Nettogewinn 62,4 Millionen Dollar (1,77 Dollar pro Einheit), was einem Anstieg von 8,1 Millionen Dollar im Vergleich zu 2023 entspricht, angetrieben durch höhere Verkaufspreise und Margen für Ethylen von Dritten. Die operativen Cashflows wuchsen auf 485,0 Millionen Dollar, ein Anstieg von 33,0 Millionen Dollar im Vergleich zu 2023.
Die Partnerschaft erklärte ihre 42. aufeinanderfolgende vierteljährliche Ausschüttung von 0,4714 Dollar pro Einheit. Das Unternehmen verschob die geplante Wartung der Petro 1 Ethylen-Anlage auf 2025, was dazu beitrug, die jährlichen Produktionsziele zu übertreffen und im zweiten Halbjahr 2024 attraktive Ethylenpreise von Dritten zu sichern. Die Wartungsarbeiten begannen im Januar 2025 und sollen etwa 60 Tage dauern.
- Net income increased 14.9% YoY to $62.4 million for full-year 2024
- Operating cash flows improved by $33.0 million to $485.0 million in 2024
- Maintained consistent quarterly distribution of $0.4714 per unit
- Higher third-party ethylene sales prices and margins in 2024
- Q4 2024 MLP distributable cash flow decreased by $1.4 million to $15.0 million vs Q4 2023
- Coverage ratio declined to 1.01x from 1.03x in previous quarter
- Expected coverage ratio to fall below 1.00x in 2025 due to Petro 1 turnaround
Insights
The Q4 2024 results reveal a strategically managed performance by Westlake Chemical Partners, with several key developments worth noting for investors. The 8.1 million year-over-year increase in net income to
The decision to defer the Petro 1 ethylene unit turnaround to 2025 proved particularly astute, allowing the partnership to capture higher third-party ethylene margins during the latter half of 2024. This timing optimization contributed to the improved annual performance, though it creates a temporary challenge in 2025. The current 60-day maintenance turnaround beginning January 2025 will likely pressure the coverage ratio below 1.00x, but the partnership's strong cash position and operating surplus provide adequate cushion to maintain the distribution.
The partnership's financial structure offers notable stability through its ethylene sales agreement with Westlake, which guarantees a
Working capital management has shown improvement, evidenced by the
Looking beyond the 2025 turnaround, the partnership appears well-positioned to benefit from improving third-party ethylene prices and margins, suggesting potential for enhanced cash flows once production normalizes. The maintenance investment, while creating short-term pressure, should support operational reliability and long-term performance stability.
-
Declared quarterly distribution of
per unit; 42nd consecutive quarterly distribution$0.47 14
Fourth quarter 2024 net income attributable to the Partnership of
For the full year 2024, net income attributable to the Partnership of
"The Partnership performed well in 2024 as we exceeded our annual production plan, in part due to the decision to defer the planned turnaround at our Petro 1 ethylene unit to 2025. By postponing the Petro 1 turnaround we were able to better capture attractive third-party ethylene prices and margins in the second half of 2024, which supported an improvement in the Partnership's distributable cash flow and coverage ratio for the full year 2024," said Jean-Marc Gilson, President and Chief Executive Officer. "At the end of January 2025, we began our planned maintenance turnaround at our Petro 1 ethylene unit, which is expected to last approximately 60 days. As is typically the case during turnaround years, the lost production during the Petro 1 turnaround may cause the Partnership's coverage ratio to dip below 1.00x this year. As has been the case in previous turnaround years when the Partnership's coverage ratio dipped below 1.00x, we estimate that the Partnership will have ample cash and operating surplus to fund distributions in excess of distributable cash flow in 2025. Looking beyond 2025, we believe recent improvement in third-party ethylene prices and margins should position the Partnership for improved cash flows once production returns to expected levels."
On January 27, 2025, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the fourth quarter of 2024 of
OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that
The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to the timing and results of our turnaround activities, including the Petro 1 turnaround, our future coverage ratio, our ability to fund distributions in excess of distributable cash flow, our outlook for third-party ethylene margins, our expectations regarding future interest rates, the ability to deliver value and returns to unitholders, our outlook for improved cash flows, and the nature of the sales agreement with Westlake, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, pandemic infectious diseases and the response thereto; operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake Corporation; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC in February 2024, and Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, which was filed with the SEC in November 2024.
This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (
Use of Non-GAAP Financial Measures
This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with
Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in
Westlake Chemical Partners LP Conference Call Information:
A conference call to discuss Westlake Chemical Partners' fourth quarter and full year 2024 results will be held Monday, February 24th, 2025 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register.vevent.com/register/BI294ab16856704d199e4792cc3d8bb4b0. A dial-in will be provided upon registration.
The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/s2462hyq and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.
|
||||||||||||||||
WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS") CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) |
||||||||||||||||
|
||||||||||||||||
|
|
Three Months Ended December 31, |
|
Twelve Months Ended December 31, |
||||||||||||
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
(In thousands of dollars, except per unit data) |
||||||||||||||
Revenue |
|
|
|
|
|
|
|
|
||||||||
Net sales—Westlake Corporation ("Westlake") |
|
$ |
260,266 |
|
|
$ |
255,306 |
|
|
$ |
950,801 |
|
|
$ |
1,026,655 |
|
Net co-products, ethylene and other sales—third parties |
|
|
29,794 |
|
|
|
41,967 |
|
|
|
185,095 |
|
|
|
164,136 |
|
Total net sales |
|
|
290,060 |
|
|
|
297,273 |
|
|
|
1,135,896 |
|
|
|
1,190,791 |
|
Cost of sales |
|
|
191,476 |
|
|
|
196,590 |
|
|
|
716,957 |
|
|
|
803,332 |
|
Gross profit |
|
|
98,584 |
|
|
|
100,683 |
|
|
|
418,939 |
|
|
|
387,459 |
|
Selling, general and administrative expenses |
|
|
6,559 |
|
|
|
7,867 |
|
|
|
28,495 |
|
|
|
29,751 |
|
Income from operations |
|
|
92,025 |
|
|
|
92,816 |
|
|
|
390,444 |
|
|
|
357,708 |
|
Other income (expense) |
|
|
|
|
|
|
|
|
||||||||
Interest expense—Westlake |
|
|
(5,771 |
) |
|
|
(6,632 |
) |
|
|
(25,701 |
) |
|
|
(26,501 |
) |
Other income, net |
|
|
1,335 |
|
|
|
1,079 |
|
|
|
5,251 |
|
|
|
4,232 |
|
Income before income taxes |
|
|
87,589 |
|
|
|
87,263 |
|
|
|
369,994 |
|
|
|
335,439 |
|
Provision for income taxes |
|
|
202 |
|
|
|
206 |
|
|
|
835 |
|
|
|
813 |
|
Net income |
|
|
87,387 |
|
|
|
87,057 |
|
|
|
369,159 |
|
|
|
334,626 |
|
Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo") |
|
|
72,391 |
|
|
|
72,758 |
|
|
|
306,767 |
|
|
|
280,343 |
|
Net income attributable to Westlake Partners |
|
$ |
14,996 |
|
|
$ |
14,299 |
|
|
$ |
62,392 |
|
|
$ |
54,283 |
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per limited partner unit attributable to Westlake Partners (basic and diluted) |
|
|
|
|
|
|
|
|
||||||||
Common units |
|
$ |
0.43 |
|
|
$ |
0.41 |
|
|
$ |
1.77 |
|
|
$ |
1.54 |
|
|
|
|
|
|
|
|
|
|
||||||||
Distributions declared per unit |
|
$ |
0.4714 |
|
|
$ |
0.4714 |
|
|
$ |
1.8856 |
|
|
$ |
1.8856 |
|
|
|
|
|
|
|
|
|
|
||||||||
MLP distributable cash flow |
|
$ |
14,958 |
|
|
$ |
16,418 |
|
|
$ |
66,864 |
|
|
$ |
62,574 |
|
|
|
|
|
|
|
|
|
|
||||||||
Distributions declared |
|
|
|
|
|
|
|
|
||||||||
Limited partner units—publicly and privately held |
|
$ |
9,954 |
|
|
$ |
9,949 |
|
|
$ |
39,809 |
|
|
$ |
39,790 |
|
Limited partner units—Westlake |
|
|
6,657 |
|
|
|
6,658 |
|
|
|
26,628 |
|
|
|
26,631 |
|
Total distributions declared |
|
$ |
16,611 |
|
|
$ |
16,607 |
|
|
$ |
66,437 |
|
|
$ |
66,421 |
|
EBITDA |
|
$ |
120,838 |
|
|
$ |
122,196 |
|
|
$ |
507,594 |
|
|
$ |
472,143 |
|
WESTLAKE CHEMICAL PARTNERS LP CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
||||||||
|
|
December 31, |
||||||
|
|
|
2024 |
|
|
|
2023 |
|
|
|
(In thousands of dollars) |
||||||
ASSETS |
|
|
|
|
||||
Current assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
58,316 |
|
|
$ |
58,619 |
|
Receivable under the Investment Management Agreement—Westlake |
|
|
134,557 |
|
|
|
94,444 |
|
Accounts receivable, net—Westlake |
|
|
31,975 |
|
|
|
49,565 |
|
Accounts receivable, net—third parties |
|
|
11,576 |
|
|
|
18,701 |
|
Inventories |
|
|
4,058 |
|
|
|
4,432 |
|
Prepaid expenses and other current assets |
|
|
444 |
|
|
|
442 |
|
Total current assets |
|
|
240,926 |
|
|
|
226,203 |
|
Property, plant and equipment, net |
|
|
903,588 |
|
|
|
943,843 |
|
Other assets, net |
|
|
143,442 |
|
|
|
146,796 |
|
Total assets |
|
$ |
1,287,956 |
|
|
$ |
1,316,842 |
|
|
|
|
|
|
||||
LIABILITIES AND EQUITY |
|
|
|
|
||||
Current liabilities (accounts payable and accrued and other liabilities) |
|
$ |
55,372 |
|
|
$ |
56,335 |
|
Long-term debt payable to Westlake |
|
|
399,674 |
|
|
|
399,674 |
|
Other liabilities |
|
|
3,596 |
|
|
|
4,583 |
|
Total liabilities |
|
|
458,642 |
|
|
|
460,592 |
|
Common unitholders—publicly and privately held |
|
|
471,328 |
|
|
|
473,513 |
|
Common unitholder—Westlake |
|
|
47,373 |
|
|
|
48,993 |
|
General partner—Westlake |
|
|
(242,572 |
) |
|
|
(242,572 |
) |
Total Westlake Partners partners' capital |
|
|
276,129 |
|
|
|
279,934 |
|
Noncontrolling interest in OpCo |
|
|
553,185 |
|
|
|
576,316 |
|
Total equity |
|
|
829,314 |
|
|
|
856,250 |
|
Total liabilities and equity |
|
$ |
1,287,956 |
|
|
$ |
1,316,842 |
|
WESTLAKE CHEMICAL PARTNERS LP CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) |
||||||||
|
|
Twelve Months Ended December 31, |
||||||
|
|
|
2024 |
|
|
|
2023 |
|
|
|
(In thousands of dollars) |
||||||
Cash flows from operating activities |
|
|
|
|
||||
Net income |
|
$ |
369,159 |
|
|
$ |
334,626 |
|
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
|
|
||||
Depreciation and amortization |
|
|
111,899 |
|
|
|
110,203 |
|
Net loss on disposition and other |
|
|
2,163 |
|
|
|
4,906 |
|
Other balance sheet changes |
|
|
1,780 |
|
|
|
2,264 |
|
Net cash provided by operating activities |
|
|
485,001 |
|
|
|
451,999 |
|
Cash flows from investing activities |
|
|
|
|
||||
Additions to property, plant and equipment |
|
|
(48,971 |
) |
|
|
(46,821 |
) |
Investments with Westlake under the Investment Management Agreement |
|
|
(40,000 |
) |
|
|
(174,116 |
) |
Maturities of investments with Westlake under the Investment Management Agreement |
|
|
— |
|
|
|
145,000 |
|
Net cash used for investing activities |
|
|
(88,971 |
) |
|
|
(75,937 |
) |
Cash flows from financing activities |
|
|
|
|
||||
Proceeds from debt payable to Westlake |
|
|
219,000 |
|
|
|
209,250 |
|
Repayment of debt payable to Westlake |
|
|
(219,000 |
) |
|
|
(209,250 |
) |
Distributions to noncontrolling interest retained in OpCo by Westlake |
|
|
(329,898 |
) |
|
|
(315,805 |
) |
Distributions to unitholders |
|
|
(66,435 |
) |
|
|
(66,420 |
) |
Net cash used for financing activities |
|
|
(396,333 |
) |
|
|
(382,225 |
) |
Net decrease in cash and cash equivalents |
|
|
(303 |
) |
|
|
(6,163 |
) |
Cash and cash equivalents at beginning of the year |
|
|
58,619 |
|
|
|
64,782 |
|
Cash and cash equivalents at end of the year |
|
$ |
58,316 |
|
|
$ |
58,619 |
|
WESTLAKE CHEMICAL PARTNERS LP RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME AND NET CASH PROVIDED BY OPERATING ACTIVITIES (Unaudited) |
||||||||||||||||||||
|
|
Three Months
|
|
Three Months Ended December 31, |
|
Twelve Months Ended December 31, |
||||||||||||||
|
|
|
2024 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
(In thousands of dollars) |
||||||||||||||||||
Net cash provided by operating activities |
|
$ |
126,071 |
|
|
$ |
132,469 |
|
|
$ |
107,671 |
|
|
$ |
485,001 |
|
|
$ |
451,999 |
|
Changes in operating assets and liabilities and other |
|
|
(21,971 |
) |
|
|
(45,082 |
) |
|
|
(20,614 |
) |
|
|
(115,842 |
) |
|
|
(117,373 |
) |
Net income |
|
|
104,100 |
|
|
|
87,387 |
|
|
|
87,057 |
|
|
|
369,159 |
|
|
|
334,626 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation, amortization and disposition of property, plant and equipment |
|
|
28,528 |
|
|
|
27,582 |
|
|
|
28,796 |
|
|
|
114,244 |
|
|
|
115,136 |
|
Less: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Contribution to turnaround reserves |
|
|
(11,903 |
) |
|
|
(11,829 |
) |
|
|
(7,682 |
) |
|
|
(43,880 |
) |
|
|
(29,520 |
) |
Maintenance capital expenditures |
|
|
(17,753 |
) |
|
|
(15,923 |
) |
|
|
(11,805 |
) |
|
|
(50,731 |
) |
|
|
(49,212 |
) |
Distributable cash flow attributable to noncontrolling interest in OpCo |
|
|
(85,093 |
) |
|
|
(72,259 |
) |
|
|
(79,948 |
) |
|
|
(321,928 |
) |
|
|
(308,456 |
) |
MLP distributable cash flow |
|
$ |
17,879 |
|
|
$ |
14,958 |
|
|
$ |
16,418 |
|
|
$ |
66,864 |
|
|
$ |
62,574 |
|
WESTLAKE CHEMICAL PARTNERS LP RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH PROVIDED BY OPERATING ACTIVITIES (Unaudited) |
||||||||||||||||||||
|
|
Three Months
|
|
Three Months Ended December 31, |
|
Twelve Months Ended December 31, |
||||||||||||||
|
|
|
2024 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
(In thousands of dollars) |
||||||||||||||||||
Net cash provided by operating activities |
|
$ |
126,071 |
|
|
$ |
132,469 |
|
|
$ |
107,671 |
|
|
$ |
485,001 |
|
|
$ |
451,999 |
|
Changes in operating assets and liabilities and other |
|
|
(21,971 |
) |
|
|
(45,082 |
) |
|
|
(20,614 |
) |
|
|
(115,842 |
) |
|
|
(117,373 |
) |
Net income |
|
|
104,100 |
|
|
|
87,387 |
|
|
|
87,057 |
|
|
|
369,159 |
|
|
|
334,626 |
|
Less: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Other income, net |
|
|
1,325 |
|
|
|
1,335 |
|
|
|
1,079 |
|
|
|
5,251 |
|
|
|
4,232 |
|
Interest expense—Westlake |
|
|
(6,698 |
) |
|
|
(5,771 |
) |
|
|
(6,632 |
) |
|
|
(25,701 |
) |
|
|
(26,501 |
) |
Provision for income taxes |
|
|
(216 |
) |
|
|
(202 |
) |
|
|
(206 |
) |
|
|
(835 |
) |
|
|
(813 |
) |
Income from operations |
|
|
109,689 |
|
|
|
92,025 |
|
|
|
92,816 |
|
|
|
390,444 |
|
|
|
357,708 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization |
|
|
28,112 |
|
|
|
27,478 |
|
|
|
28,301 |
|
|
|
111,899 |
|
|
|
110,203 |
|
Other income, net |
|
|
1,325 |
|
|
|
1,335 |
|
|
|
1,079 |
|
|
|
5,251 |
|
|
|
4,232 |
|
EBITDA |
|
$ |
139,126 |
|
|
$ |
120,838 |
|
|
$ |
122,196 |
|
|
$ |
507,594 |
|
|
$ |
472,143 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250218475847/en/
Contact—(713) 585-2900
Investors—Steve Bender
Media—L. Benjamin Ederington
Source: Westlake Chemical Partners
FAQ
What was WLKP's net income for Q4 2024?
How much is WLKP's Q4 2024 quarterly distribution?
What was WLKP's full-year 2024 operating cash flow?
How long will WLKP's Petro 1 turnaround in 2025 last?